Yahoo Finance

Cepheid Ships Record Xpert MTB/RIF to Mark World TB Day - Analyst Blog

To honor the World TB Day on Mar 24, 2015, California-based molecular diagnostics provider Cepheid CPHD along with the National Health Laboratory Services (NHLS) of South Africa, recently announced ...
Yahoo Finance

FDA Okays Cepheid Xpert Carba-R for Drug-Resistant Genes

CepheidCPHD recently won the FDA clearance for marketing its Xpert Carba-R diagnostic test, which is capable of accurately identifying the most common 5 different families of carbapenem-antibiotics ...
Nasdaq

Cepheid Announces World Health Organization Prequalification of the Xpert® MTB/XDR test

SUNNYVALE, Calif., Oct. 28, 2025 /PRNewswire/ -- Cepheid today announced that its Xpert® MTB/XDR test has been awarded prequalification status by the World Health Organization (WHO), marking a new ...
technologynetworks

Cepheid Receives FDA Clearance for Xpert Norovirus

Cepheid has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® Norovirus, a qualitative in vitro diagnostic test for expeditious identification and differentiation of ...
Nasdaq

Cepheid Announces World Health Organization Prequalification of Xpert HIV-1 Qualitative Test

SUNNYVALE, Calif., April 3, 2024 /PRNewswire/ -- Cepheid today announced that Xpert® HIV-1 Qual XC has been awarded World Health Organization (WHO) prequalification. Inclusion on the prequalification ...
Business Insider

Cepheid Receives Emergency Use Authorization from FDA for Xpert® Mpox

SUNNYVALE, Calif., Feb. 14, 2023 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration for Xpert Mpox, which runs on ...
Seeking Alpha

Cepheid Receives FDA Clearance for Xpert® Xpress GBS

Redesigned test introduces two new targets to improve coverage and sensitivity for Group B Streptococcus intrapartum testing for pregnant females Group B Streptococcus (GBS) is the leading cause of ...
Monthly Prescribing Reference

Cepheid Xpert C. difficile/Epi Assay Approved

The FDA has approved Cepheid Xpert C. difficile/Epi assay for the detection of the toxin B gene associated with Clostridium difficile infection. The Cepheid Xpert C. difficile/Epi assay determines if ...
Medindia

Cepheid's Xpert TV Now Cleared For Testing Symptomatic And Asymptomatic Men

First and Only Trichomonas NAAT Test with Male Urine Claims Cleared for Use in United States Following initial clearance of Xpert TV for three types of female specimens in October of 2015, the latest ...
technologynetworks

Cepheid's Xpert™ MRSA PCR-Based Drug Resistant Test Receives FDA Clearance

Cepheid has announced that it has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert™ MRSA test, which runs on the GeneXpert® System, for the detection of ...
PR Newswire

Cepheid Receives CE Mark for Xpert® NPM1 Mutation

The European LeukemiaNet recommends quantitative molecular assessment of NPM1 by qPCR as part of minimal residual disease (MRD) monitoring of patients with NPM1-mutated AML 1. Acute myeloid leukemia ...